Literature DB >> 24297759

Factors associated with duration before receiving definitive diagnosis of narcolepsy among Japanese patients affected with the disorder.

Yoichiro Ueki1, Kenichi Hayashida, Yoko Komada, Masaki Nakamura, Mina Kobayashi, Makio Iimori, Yuichi Inoue.   

Abstract

BACKGROUND: Narcolepsy (NA) is a sleep disorder characterized by excessive daytime sleepiness and an increased propensity of rapid eye movement sleep. If left untreated, NA can lead to academic underachievement or job loss because of dozing off or mistakes caused by inattentiveness due to sleepiness.
PURPOSE: Although untreated narcolepsy patients may suffer from many social disadvantages due to excessive daytime sleepiness, mostly it takes a long time to receive a definitive diagnosis of the disorder. This retrospective study investigated factors related to the period until definitive diagnosis among patients with narcolepsy in Japan.
METHODS: We enrolled 181 consecutive patients (108 men, 73 women; mean age 37.6 ± 16.6 years old; narcolepsy with cataplexy/narcolepsy without cataplexy = 131:50). Multivariate logistic regression analysis was performed with period until definitive diagnosis as the dependent variable and descriptive clinical variables as the independent variables.
RESULTS: The mean period until receiving the diagnosis among the participants was 9.9 ± 10.1 years. More than half of the patients first learned about the disorder from information provided by the media. Multivariate logistic analysis indicated that adult onset (p < 0.01), onset in 1995 or later (p < 0.001), and first learning about the disorder from a sleep disorder specialist physician or a general practitioner (p < 0.001) were associated with a time taken for receiving a definitive diagnosis less than or equal to the median value (7 years).
CONCLUSION: Improving access to information about the concept of the disorder and the medical institutions specialized in sleep disorders, especially via the Internet, would be necessary to promote early diagnosis of the disorder.

Entities:  

Mesh:

Year:  2014        PMID: 24297759     DOI: 10.1007/s12529-013-9371-5

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  28 in total

1.  Public perception of stroke warning signs and knowledge of potential risk factors.

Authors:  A M Pancioli; J Broderick; R Kothari; T Brott; A Tuchfarber; R Miller; J Khoury; E Jauch
Journal:  JAMA       Date:  1998 Apr 22-29       Impact factor: 56.272

2.  Health-related quality of life effects of modafinil for treatment of narcolepsy.

Authors:  K M Beusterien; A E Rogers; J A Walsleben; H A Emsellem; J A Reblando; L Wang; M Goswami; B Steinwald
Journal:  Sleep       Date:  1999-09-15       Impact factor: 5.849

3.  Health-related quality of life in narcolepsy.

Authors:  E Daniels; M A King; I E Smith; J M Shneerson
Journal:  J Sleep Res       Date:  2001-03       Impact factor: 3.981

4.  Narcolepsy in Southern Chinese patients: clinical characteristics, HLA typing and seasonality of birth.

Authors:  Y K Wing; L Chen; S Y Y Fong; M H L Ng; C K W Ho; S H Cheng; N L S Tang; A M Li
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-04-03       Impact factor: 10.154

5.  A clinical picture of child and adolescent narcolepsy.

Authors:  R E Dahl; J Holttum; L Trubnick
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994 Jul-Aug       Impact factor: 8.829

6.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

Review 7.  Diagnosis of narcolepsy and idiopathic hypersomnia. An update based on the International classification of sleep disorders, 2nd edition.

Authors:  Michel Billiard
Journal:  Sleep Med Rev       Date:  2007-07-23       Impact factor: 11.609

8.  Health-related quality of life among drug-naïve patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time.

Authors:  Akiko Ozaki; Yuichi Inoue; Toru Nakajima; Kenichi Hayashida; Makoto Honda; Yoko Komada; Kiyohisa Takahashi
Journal:  J Clin Sleep Med       Date:  2008-12-15       Impact factor: 4.062

9.  Community education for cardiovascular health.

Authors:  J W Farquhar; N Maccoby; P D Wood; J K Alexander; H Breitrose; B W Brown; W L Haskell; A L McAlister; A J Meyer; J D Nash; M P Stern
Journal:  Lancet       Date:  1977-06-04       Impact factor: 79.321

10.  The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy.

Authors:  M B Scharf; D Brown; M Woods; L Brown; J Hirschowitz
Journal:  J Clin Psychiatry       Date:  1985-06       Impact factor: 4.384

View more
  3 in total

1.  Idling for Decades: A European Study on Risk Factors Associated with the Delay Before a Narcolepsy Diagnosis.

Authors:  Zhongxing Zhang; Yves Dauvilliers; Giuseppe Plazzi; Geert Mayer; Gert Jan Lammers; Joan Santamaria; Markku Partinen; Sebastiaan Overeem; Rafael Del Rio Villegas; Karel Sonka; Rosa Peraita-Adrados; Raphaël Heinzer; Aleksandra Wierzbicka; Birgit Högl; Mauro Manconi; Eva Feketeova; Antonio Martins da Silva; Jitka Bušková; Claudio L A Bassetti; Lucie Barateau; Fabio Pizza; Elena Antelmi; Jari K Gool; Rolf Fronczek; Carles Gaig; Ramin Khatami
Journal:  Nat Sci Sleep       Date:  2022-05-31

2.  Frequencies and Associations of Narcolepsy-Related Symptoms: A Cross-Sectional Study.

Authors:  Lenise Jihe Kim; Fernando Morgadinho Coelho; Camila Hirotsu; Paula Araujo; Lia Bittencourt; Sergio Tufik; Monica Levy Andersen
Journal:  J Clin Sleep Med       Date:  2015-12-15       Impact factor: 4.062

3.  Narcolepsy - Between the dream and reality.

Authors:  Fernando Morgadinho Santos Coelho
Journal:  Sleep Sci       Date:  2014-08-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.